exp date isn't null, but text field is
Macrophage activation syndrome (MAS) is a rare hyperinflammatory condition, one of the increasingly-recognised cytokine storms, seen in children and adults with underlying rheumatological disorders. MAS requires prompt recognition and aggressive treatment as untreated the mortality rate is 8-22%.
This guideline focusses on MAS in the context of rheumatological disorders. If the child does not have a known underlying diagnosis, the differential diagnoses of primary or secondary HLH and MAS as part of the initial presentation of a rheumatological disorder should be considered.
Last reviewed: 01 March 2022
Next review: 31 March 2025
Author(s): Scottish Paediatric & Adolescent Rheumatology Network
Approved By: Scottish Paediatric & Adolescent Rheumatology Network
Document Id: NSD610-013.05